Correlation Between Milestone Pharmaceuticals and 23Andme Holding

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and 23Andme Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and 23Andme Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and 23Andme Holding Co, you can compare the effects of market volatilities on Milestone Pharmaceuticals and 23Andme Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of 23Andme Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and 23Andme Holding.

Diversification Opportunities for Milestone Pharmaceuticals and 23Andme Holding

-0.6
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Milestone and 23Andme is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and 23Andme Holding Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 23Andme Holding and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with 23Andme Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 23Andme Holding has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and 23Andme Holding go up and down completely randomly.

Pair Corralation between Milestone Pharmaceuticals and 23Andme Holding

Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to generate 0.72 times more return on investment than 23Andme Holding. However, Milestone Pharmaceuticals is 1.4 times less risky than 23Andme Holding. It trades about -0.01 of its potential returns per unit of risk. 23Andme Holding Co is currently generating about -0.08 per unit of risk. If you would invest  320.00  in Milestone Pharmaceuticals on August 29, 2024 and sell it today you would lose (133.00) from holding Milestone Pharmaceuticals or give up 41.56% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Milestone Pharmaceuticals  vs.  23Andme Holding Co

 Performance 
       Timeline  
Milestone Pharmaceuticals 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Milestone Pharmaceuticals are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Milestone Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.
23Andme Holding 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days 23Andme Holding Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Milestone Pharmaceuticals and 23Andme Holding Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Milestone Pharmaceuticals and 23Andme Holding

The main advantage of trading using opposite Milestone Pharmaceuticals and 23Andme Holding positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, 23Andme Holding can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 23Andme Holding will offset losses from the drop in 23Andme Holding's long position.
The idea behind Milestone Pharmaceuticals and 23Andme Holding Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Equity Valuation
Check real value of public entities based on technical and fundamental data
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Technical Analysis
Check basic technical indicators and analysis based on most latest market data